Scott Tarriff, CEO: Eagle Pharmaceuticals EGRX Sell · Filed 23/11/03

Trade details

Type: Insider sale
Amount: $150,983.5
Shares · price: 10,925 sh · $13.82 a share
Held after: 556,141 sh
Stock: Eagle Pharmaceuticals EGRX
Person: Scott TarriffCEO
Trade date: 23/11/01
Filed: 23/11/03
Days to filing: 2 days

Sold 1.9% of holdings

Share of holding sold: 1.9%

Eagle Pharmaceuticals trades, last 26 weeks

What else happened in Eagle Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/10/02~23/12/01

Scott Tarriff's recent trades

Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$148.3K
10,694 sh
$148.3K
Filed 23/11/03
Traded 23/11/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.9K
9,511 sh
$144.9K
Filed 23/10/04
Traded 23/10/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.4K
10,024 sh
$144.4K
Filed 23/10/04
Traded 23/10/03
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$10.7K
710 sh
$10.7K
Filed 23/10/04
Traded 23/10/03
Scott TarriffCEO
SellEagle Pharmaceuticals
Sell
Eagle Pharmaceuticals
EGRX
$299.7K
15,000 sh
$299.7K
Filed 23/05/18
Traded 23/05/16